Hematology TimesFDA grants priority review to NDA for copanlisibMay 18, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCompound could treat lymphoma, myelomaMay 17, 2017Lymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesIntensive chemo upfront means DHL patients can skip HSCTMay 16, 2017Lymphoma & Plasma Cell DisordersTransplantationNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesNovel inhibitor proves ‘potent’ in hematologic malignanciesMay 9, 2017AnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLMyelodysplastic SyndromeHodgkin Lymphoma
Hematology TimesIV and SC rituximab produce similar results in FLMay 9, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesEMA recommends orphan status for drug for DLBCLApril 28, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesProgram allows select Europeans access to belinostatApril 27, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesDrug receives fast track designation for follicular lymphomaApril 26, 2017Lymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesCHMP recommends approval for rituximab biosimilarApril 23, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesSecond cancers take greater toll on younger patientsApril 21, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesCAR T-cell therapy receives breakthrough designationApril 19, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesInhibitor exhibits activity against hematologic malignanciesApril 18, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaNon-Hodgkin LymphomaAggressive LymphomasFollicular Lymphoma
Hematology TimesLeukemia, NHL more common in African-born blacks than US-born blacksApril 14, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesTopical HDAC inhibitor shows activity in MFApril 13, 2017Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesCancer risk, burden expected to shift in HIV populationApril 11, 2017Lymphoma & Plasma Cell DisordersHodgkin LymphomaNon-Hodgkin LymphomaAggressive Lymphomas
